The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies
ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.
These disclosures were last reviewed on the 18-11-2024.
ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it's “principal” place of business is in the United Kingdom.
UK City Code on Takeovers and Mergers:- Valirx is subject to the UK City Code on Takeovers and Mergers.
The Total Number of AIM Securities in issue with nominal value of 0.1p is 132,348,673
The information below was last updated on 18 November 2024.
The percentage of AIM Securities not in public hands is approximately 23%.
Shareholder(s) with more than 3%
Shareholders | Number of Shares | Percentage of Total |
---|---|---|
Mr Adam Hargreaves | 7,749,163 | 5.89% |
Sanderson Capital Partners Ltd | 5,000,000 | 3.78% |
Shareholders | Number of Shares | Percentage of Total |
---|---|---|
Directors (combined) | 3,887,327 | 2.34% |
Mark Eccleston | 1,976,957 | 1.49% |
Gerry Desler | 195,334 | 0.15% |
Adrian de Courcey | 871,036 | 0.65% |
Cathy Tralau-Stewart | 66,666 | 0.05% |
Martin Gouldstone | None | None |
Shard Capital Partners LLP,
70 Mark Lane,
London,
EC3R 7NQ.
Tel: +44 (0) 203 791 7000
www.shardcaptial.com
Cairn Financial Advisers LLP,
80 Cheapside,
London,
EC2V 6EE
Tel: +44 (0) 207 213 0880
www.cairnfin.com
Neville Registrars Limited,
Neville House,
Steelpark Road,
Halesowen
B62 8HD
Email:info@nevilleregistrars.co.uk
Tel: +44 (0) 121585 1131
www.nevilleregistrars.co.uk
DACBeachcroft LLP,
25 Walbrook,
London,
EC4N 8AF
Tel: +44 (0) 207 242 1011
www.dacbeachcroft.com
Adler Shine LLP,
Aston House,
Cornwall Avenue,
Finchley,
N3 1LF
Tel: +44 (0) 208 371 3000
www.adlershine.com
The Co-operative Bank,
PO Box 250,
Delph House,
Southway,
Skelmersdale,
WN8 6WT
United Kingdom
The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.
The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.
These arrangements are also disclosed in our Annual Report and Accounts.
These disclosures were last reviewed on the 12-08-2024.